Enrollment of patients with lung and colorectal cancers onto clinical trials

Journal of Oncology Practice

Volumn 9, Issue 2, 2013, Pages

  Fouad, Mona N ^a   Lee, Jeannette Y ^a   Catalano, Paul J ^a   Vogt, Thomas M ^a   Zafar, Syed Yousuf ^a   West, Dee W ^a   Simon, Christian ^a   Klabunde, Carrie N ^a   Kahn, Katherine L ^a   Weeks, Jane C ^a   Kiefe, Catarina I ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; DEMOGRAPHY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; INCOME; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIMARY TUMOR; RACE; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CANCER CARE FACILITIES; CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; DATA COLLECTION; DEMOGRAPHY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; SEX FACTORS; SPECIALIZATION; YOUNG ADULT;

EID: 84882776229     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2012.000598     Document Type: Article

References (27)

1. Murthy VH, Krumholz HM, Gross CP: Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291:2720-2726, 2004 (Pubitemid 38725421)
2. Stewart JH, Bertoni AG, Staten JL, et al: Participation in surgical oncology clinical trials: Gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 14:3328-3334, 2007 (Pubitemid 350160101)
3. Du W, Gadgeel SM, Simon MS: Predictors of enrollment in lung cancer clinical trials. Cancer 106:420-425, 2006 (Pubitemid 43100453)
4. Nass SJ, Moses HL, Mendelsohjn J (eds): A National Cancer Clinical Trials System for the 21st Century. Washington, DC, National Academies Press, 2010
5. Faltering Cancer Trials. New York Times, April 24, 2010:WK11
6. Hearing on FY 2011 National Institutes of Health budget before the Senate Appropriations Committee: 111th Cong, 2nd Sess, May 5, 2010
7. Young RC: Cancer clinical trials: A chronic but curable crisis. N Engl J Med 363:306-309, 2010
8. Ford JG, Howerton MW, Lai GY, et al: Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer 112:228-242, 2008
9. Ayanian JZ, Chrischilles EA, Fletcher RH, et al: Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 22:2992-2996, 2004
10. Cancer Care Outcomes Research and Surveillance Consortium: Protocol and instruments. http://www.cancors.org/public
11. Sateren WB, Trimble EL, Abrams J, et al: How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20:2109-2117, 2002 (Pubitemid 34408802)
12. Colon-Otero G, Smallridge RC, Solberg LA Jr, et al: Disparities in participation in cancer clinical trials in the United States: A symptom of a healthcare system in crisis. Cancer 112:447-454, 2008 (Pubitemid 351186183)
13. Baquet CR, Ellison GL, Mishra SI: Analysis of Maryland cancer patient participation in National Cancer Institute-supported cancer treatment clinical trials. J Clin Oncol 26:3380-3386, 2008
14. Go RS, Frisby KA, Lee JA, et al: Clinical trial accrual among new cancer patients at a community-based cancer center. Cancer 106:426-433, 2006 (Pubitemid 43100454)
15. Schroen AT, Brenin DR: Clinical trial priorities among surgeons caring for breast cancer patients. Am J Surg 195:474-480, 2008 (Pubitemid 351417480)
16. Movsas B, Moughan J, Owen J, et al: Who enrolls onto clinical oncology trials? A radiation Patterns of Care Study analysis. Int J Radiat Oncol Biol Phys 68:1145-1150, 2007 (Pubitemid 47048577)
17. Klabunde CN, Keating NL, Potosky AL, et al: A population-based assessment of specialty physician involvement in cancer clinical trials. J Natl Cancer Inst 103:384-397, 2011
18. Tanai C, Nokihara H, Yamamoto S, et al: Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials. Br J Cancer 100:1037-1042, 2009
19. Raftery J, Kerr C, Hawker S, et al: Paying clinicians to join clinical trials: A review of guidelines and interview study of trialists. Trials 10:15, 2009
20. Bodenheimer T: Uneasy alliance: Clinical investigators and the pharmaceutical industry. N Engl J Med 342:1539-1544, 2000
21. Epstein AM: Paying for performance in the United States and abroad. N Engl J Med 355:406-408, 2006
22. Epstein AM, Lee TH, Hamel MB: Paying physicians for high-quality care. N Engl J Med 350:406-410, 2004 (Pubitemid 38101637)
23. Joseph G, Dohan D: Diversity of participants in clinical trials in an academic medical center: The role of the "Good Study Patient?" Cancer 115:608-615, 2009
24. Albrecht TL, Eggly SS, Gleason ME, et al: Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol 26:2666-2673, 2008
25. Emanuel EJ, Schnipper LE, Kamin DY, et al: Costs of conducting clinical research. J Clin Oncol 21:4145-4150, 2003
26. Costa LJ, Xavier AC, del Giglio A: Negative results in cancer clinical trials: Equivalence or poor accrual? Control Clin Trials 25:525-533, 2004 (Pubitemid 39299161)
27. Korn EL, Freidlin B, Mooney M, et al: Accrual experience of National Cancer Institute Cooperative Group phase III trials activated from 2000 to 2007. J Clin Oncol 28:5197-5201, 2010